Kiniksa Pharmaceuticals
KNSA
KNSA
101 hedge funds and large institutions have $330M invested in Kiniksa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $3.15M | Put options by funds: $3.54M
18% less capital invested
Capital invested by funds: $402M → $330M (-$71.3M)
Holders
101
Holding in Top 10
–
Calls
$3.15M
Puts
$3.54M
Top Buyers
| 1 | +$7.07M | |
| 2 | +$5.47M | |
| 3 | +$4.62M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.27M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.27M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$11.1M | |
| 3 | -$5.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.97M |
| 5 |
Millennium Management
New York
|
-$2.51M |